Liver Cancer Market Trend Analysis and Projected Growth By 2030

Market Dynamics
The global market for liver cancer is anticipated to demonstrate consistent revenue growth over the forecast period. This increase is primarily attributed to the escalating prevalence of liver cancer cases worldwide.
Liver cancer initiates when liver cells undergo uncontrolled growth. Common symptoms include weight loss, loss of appetite, abdominal swelling, upper abdominal pain, nausea, vomiting, fatigue, yellow discoloration of the skin, and chalky stools.
Causes include chronic infections such as hepatitis B or C, cirrhosis, certain inherited liver diseases, diabetes, and excessive alcohol consumption. Organic and Inorganic Strategies Adopted
• In March 2021, Helsinn Group joined forces with QED Therapeutics to co-develop and commercialize infigratinib for cholangiocarcinoma treatment.
• Rafarma Pharmaceuticals, Inc., in December 2020, announced the approval of Yttrium-90 production and sale for inoperable liver cancer treatment.
Major Companies in the Market
• Astellas Pharma Inc.
• EMERGENT
• Gilead Sciences, Inc.
• Eisai Co., Ltd.
• Alnylam Pharmaceuticals, Inc.
• Exelixis, Inc.
• Eli Lilly and Company
• Bristol-Myers Squibb
• Amgen Inc.
• Bayer AG
• Novartis AG
• Abbott Laboratories
• Merck & Co., Inc.
• Pfizer Inc.
• Hoffmann-La Roche Ltd
Request for Sample @https://www.reportsanddata.com/download-free-sample/5263
Factors Supporting Market Growth
Drivers:
1. The growing prevalence of liver cancer due to unhealthy habits in the expanding population is a major driver of revenue growth.
2. The aging population, particularly those at higher risk of liver failure and other chronic diseases, contributes to the market's growth.
3. Technological advancements in liver cancer treatment, increased research, and drug development are supporting market expansion.
Restraints:
1. The high cost of available liver cancer treatments and adverse reactions from these treatments are major factors limiting market growth.
Opportunities:
1. Advancements in treatment technologies, improved healthcare facilities, government initiatives for awareness, and increased healthcare investments present lucrative growth opportunities.
Geographic Market Scenario
Largest Market Share:
• North America leads as the largest market for liver cancer, attributed to rising healthcare expenditure, increased awareness, and a growing incidence of liver cancer.
Fastest Growing Market:
• The Asia Pacific liver cancer market is expected to witness the fastest growth, driven by an increasing number of patients, government initiatives for awareness, and rising demand for treatment.
Key Market Trends and Innovation
1. The Second Affiliated Hospital of Guangzhou Medical University, China, is conducting a Phase 3 clinical trial on the infusion of PD1/PDL1 inhibitor for advanced hepatocellular carcinoma.
2. In November 2020, F. Hoffmann-La Roche Ltd. received European Commission approval for the Avastin with Tecentriq combination for liver cancer treatment.
3. In May 2020, the FDA approved the use of bevacizumab in combination with atezolizumab for early treatment of liver cancer.
Report Overview
This comprehensive report provides historical data, forecasts, and revenue growth globally, regionally, and at a country level from 2019-2030. It includes industry trends, analysis, consumption patterns, market strategies, segment revenue, and competitive landscape. The report covers industry trends, drivers, restraints, opportunities, threats, and impact analysis.
Market Segmentation
Type Outlook (Revenue, USD Billion; 2019-2030)
• Hepatocellular Carcinoma
• Fibrolamellar Liver Cancer
• Cholangiocarcinoma
• Angiosarcoma
• Liver Metastasis
• Hepatoblastoma
Treatment Outlook (Revenue, USD Billion; 2019-2030)
• Antiviral Drugs
• Immunosuppressant
• Targeted Therapy Drugs
• Chemotherapeutic Drugs
• Immunoglobulins
• Corticosteroids
• Vaccines
Route of Administration (Revenue, USD Billion; 2019-2030)
• Oral
• Parenteral
End User Outlook (Revenue, USD Billion; 2019-2030)
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
Distribution Channel Outlook (Revenue, USD Billion; 2019-2030)
• Offline
• Online
Regional Outlook (Revenue, USD Million; 2019-2030)
• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Sweden
• BENELUX
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of APAC
• Latin America
• Brazil
• Rest of LATAM
• Middle East & Africa
• Saudi Arabia
• UAE
• South Africa
• Israel
• Rest of MEA
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/5263
Thank you for reading global report. We also offer customized research reports as per client requirement. Kindly contact us for to know more about the feature and our team will provide you a well-curated report in the stipulated time.
Explore Trending Reports:
Automotive Repair & Maintenance Service Market-https://www.globenewswire.com/news-release/2019/03/27/1774167/0/en/Autom...
Automotive Alternative Propulsion Market-https://www.globenewswire.com/news-release/2020/01/07/1967484/0/en/Autom...
Refrigerated Transport Market-https://www.globenewswire.com/news-release/2020/04/16/2017606/0/en/Refri...
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a nconcrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Browse Latest Press Release: https://www.reportsanddata.com/press-release